Anula Jayasuriya - Director at Lineage Cell Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
LCTX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Anula Jayasuriya - trading volume in the past year for Lineage Cell Therapeutics, Inc.

Holdings reported by Anula Jayasuriya for Lineage Cell Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares, no par value 10K $10.9K $1.09 Dec 29, 2023 Direct
Stock Option (Right to Buy) 75K Jul 1, 2024 Direct Common Shares

Transactions reported by Anula Jayasuriya for Lineage Cell Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.